Cabozantinib in medullary thyroid carcinoma: time to focus the spotlight on this rare disease

J Clin Oncol. 2011 Jul 1;29(19):2616-8. doi: 10.1200/JCO.2010.34.0505. Epub 2011 May 23.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anilides / therapeutic use*
  • Antineoplastic Agents / therapeutic use
  • Carcinoma / drug therapy*
  • Carcinoma, Neuroendocrine
  • Clinical Trials as Topic
  • Cohort Studies
  • Genotype
  • Humans
  • Medical Oncology / methods
  • Mutation
  • Phenotype
  • Pyridines / therapeutic use*
  • Thyroid Neoplasms / drug therapy
  • Treatment Outcome

Substances

  • Anilides
  • Antineoplastic Agents
  • Pyridines
  • cabozantinib

Supplementary concepts

  • Thyroid cancer, medullary